{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T21:36:13Z","timestamp":1783632973262,"version":"3.55.0"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"vor","delay-in-days":1129,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T00:00:00Z","timestamp":1665360000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["KLI-818B"],"award-info":[{"award-number":["KLI-818B"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["KLI\u2010818B"],"award-info":[{"award-number":["KLI\u2010818B"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Secondary, or functional, mitral regurgitation (FMR) was recently recognized as a separate clinical entity, complicating heart failure with reduced ejection fraction (HFrEF) and entailing particularly poor outcome. Currently, there is a lack of targeted therapies for FMR due to the fact that pathomechanisms leading to FMR progression are incompletely understood. In this study, we sought to perform metabolomic profiling of HFrEF patients with severe FMR, comparing results to patients with no or mild FMR.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>Targeted plasma metabolomics and untargeted eicosanoid analyses were performed in samples drawn from HFrEF patients (n = 80) on optimal guideline-directed medical therapy. Specifically, 17 eicosanoids and 188 metabolites were analysed. Forty-seven patients (58.8%) had severe FMR, and 33 patients (41.2%) had no or non-severe FMR. Comparison of eicosanoid levels between groups, accounting for age, body mass index, and sex, revealed significant up-regulation of six eicosanoids (11,12-EET, 13(R)-HODE, 12(S)-HETE, 8,9-DiHETrE, metPGJ2, and 20-HDoHE) in severe FMR patients. Metabolites did not differ significantly. In patients with severe FMR, but not in those without severe FMR, levels of 8,9-DiHETrE above a cut-off specified by receiver-operating characteristic analysis independently predicted all-cause mortality after a median follow-up of 43 [interquartile range 38, 48] months [hazard ratio 12.488 (95% confidence interval 3.835\u201340.666), P &amp;lt; 0.0001].<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We report the up-regulation of various eicosanoids in patients with severe FMR, with 8,9-DiHETrE appearing to predict mortality. Our observations may serve as a nucleus for further investigations into the causes and consequences of metabolic derangements in this important valvular abnormality.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ehf2.14160","type":"journal-article","created":{"date-parts":[[2022,10,11]],"date-time":"2022-10-11T01:46:31Z","timestamp":1665452791000},"page":"311-321","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Metabolomics Implicate Eicosanoids in Severe Functional Mitral Regurgitation"],"prefix":"10.1093","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5324-6336","authenticated-orcid":false,"given":"Thomas M.","family":"Hofbauer","sequence":"first","affiliation":[{"name":"Department of Cardiology, Internal Medicine II, Medical University of Vienna , Waehringer Guertel 18-20, A-1090, Vienna ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Distelmaier","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Internal Medicine II, Medical University of Vienna , Waehringer Guertel 18-20, A-1090, Vienna ,","place":["Austria"]},{"name":"Herz Zentrum Waehring , Vienna ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Besnik","family":"Muqaku","sequence":"additional","affiliation":[{"name":"Institute of Analytical Chemistry, University of Vienna , Vienna ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Spinka","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Internal Medicine II, Medical University of Vienna , Waehringer Guertel 18-20, A-1090, Vienna ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika","family":"Seidl","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Internal Medicine II, Medical University of Vienna , Waehringer Guertel 18-20, A-1090, Vienna ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrike T.","family":"Arfsten","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Internal Medicine II, Medical University of Vienna , Waehringer Guertel 18-20, A-1090, Vienna ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Hagn","sequence":"additional","affiliation":[{"name":"Institute of Analytical Chemistry, University of Vienna , Vienna ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Meier-Menches","sequence":"additional","affiliation":[{"name":"Institute of Analytical Chemistry, University of Vienna , Vienna ,","place":["Austria"]},{"name":"Joint Metabolome Facility, University of Vienna and Medical University of Vienna , Vienna ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp E.","family":"Bartko","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Internal Medicine II, Medical University of Vienna , Waehringer Guertel 18-20, A-1090, Vienna ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noemi","family":"Pavo","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Internal Medicine II, Medical University of Vienna , Waehringer Guertel 18-20, A-1090, Vienna ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Hoke","sequence":"additional","affiliation":[{"name":"Department of Angiology, Internal Medicine II, Medical University of Vienna , Vienna ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suriya","family":"Prausmueller","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Internal Medicine II, Medical University of Vienna , Waehringer Guertel 18-20, A-1090, Vienna ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregor","family":"Heitzinger","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Internal Medicine II, Medical University of Vienna , Waehringer Guertel 18-20, A-1090, Vienna ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dietmar","family":"Pils","sequence":"additional","affiliation":[{"name":"Joint Metabolome Facility, University of Vienna and Medical University of Vienna , Vienna ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene M.","family":"Lang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Internal Medicine II, Medical University of Vienna , Waehringer Guertel 18-20, A-1090, Vienna ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Hengstenberg","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Internal Medicine II, Medical University of Vienna , Waehringer Guertel 18-20, A-1090, Vienna ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin P.","family":"H\u00fclsmann","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Internal Medicine II, Medical University of Vienna , Waehringer Guertel 18-20, A-1090, Vienna ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Gerner","sequence":"additional","affiliation":[{"name":"Joint Metabolome Facility, University of Vienna and Medical University of Vienna , Vienna ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Goliasch","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Internal Medicine II, Medical University of Vienna , Waehringer Guertel 18-20, A-1090, Vienna ,","place":["Austria"]},{"name":"Herz Zentrum Waehring , Vienna ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,10,10]]},"reference":[{"key":"2026012114121113300_ehf214160-bib-0001","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.jacc.2015.02.009","article-title":"Secondary mitral regurgitation in heart failure: pathophysiology, prognosis, and therapeutic considerations","volume":"65","author":"Asgar","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2026012114121113300_ehf214160-bib-0002","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/S0140-6736(16)00558-4","article-title":"Mitral valve disease\u2014current management and future challenges","volume":"387","author":"Nishimura","year":"2016","journal-title":"Lancet"},{"key":"2026012114121113300_ehf214160-bib-0003","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.jacc.2007.07.093","article-title":"Mitral regurgitation augments post-myocardial infarction remodeling failure of hypertrophic compensation","volume":"51","author":"Beeri","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"2026012114121113300_ehf214160-bib-0004","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1093\/ehjci\/jey023","article-title":"Evolution of secondary mitral regurgitation","volume":"19","author":"Bartko","year":"2018","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026012114121113300_ehf214160-bib-0005","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"2026012114121113300_ehf214160-bib-0006","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/eurjhf\/hfp051","article-title":"Long-term prognosis of medically treated patients with functional mitral regurgitation and left ventricular dysfunction","volume":"11","author":"Agricola","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"2026012114121113300_ehf214160-bib-0007","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/eurheartj\/ehx402","article-title":"Refining the prognostic impact of functional mitral regurgitation in chronic heart failure","volume":"39","author":"Goliasch","year":"2018","journal-title":"Eur Heart J"},{"key":"2026012114121113300_ehf214160-bib-0008","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13159","article-title":"Phenotyping progression of secondary mitral regurgitation in chronic systolic heart failure","volume":"49","author":"Arfsten","year":"2019","journal-title":"Eur J Clin Invest"},{"key":"2026012114121113300_ehf214160-bib-0009","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1016\/j.jacc.2016.09.972","article-title":"The emerging role of metabolomics in the diagnosis and prognosis of cardiovascular disease","volume":"68","author":"Ussher","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2026012114121113300_ehf214160-bib-0010","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.jchf.2017.07.009","article-title":"Targeted metabolomic profiling of plasma and survival in heart failure patients","volume":"5","author":"Lanfear","year":"2017","journal-title":"JACC Heart Fail"},{"key":"2026012114121113300_ehf214160-bib-0011","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222112029","article-title":"Effects of arachidonic acid metabolites on cardiovascular health and disease","volume":"22","author":"Zhou","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2026012114121113300_ehf214160-bib-0012","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1194\/jlr.E400004-JLR200","article-title":"A comprehensive classification system for lipids","volume":"46","author":"Fahy","year":"2005","journal-title":"J Lipid Res"},{"key":"2026012114121113300_ehf214160-bib-0013","doi-asserted-by":"crossref","DOI":"10.3390\/biom11010113","article-title":"Eicosanoid content in fetal calf serum accounts for reproducibility challenges in cell culture","volume":"11","author":"Niederstaetter","year":"2021","journal-title":"Biomolecules"},{"key":"2026012114121113300_ehf214160-bib-0014","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1161\/CIRCRESAHA.117.311002","article-title":"Cardiovascular metabolomics","volume":"122","author":"McGarrah","year":"2018","journal-title":"Circ Res"},{"key":"2026012114121113300_ehf214160-bib-0015","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1161\/RES.0000000000000097","article-title":"Assessing cardiac metabolism: a scientific statement from the American Heart Association","volume":"118","author":"Taegtmeyer","year":"2016","journal-title":"Circ Res"},{"key":"2026012114121113300_ehf214160-bib-0016","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1002\/ejhf.2339","article-title":"Integration of imaging and circulating biomarkers in heart failure: a consensus document by the Biomarkers and Imaging Study Groups of the Heart Failure Association of the European Society of Cardiology","volume":"23","author":"Moura","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"2026012114121113300_ehf214160-bib-0017","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13381","article-title":"Secondary mitral regurgitation\u2014insights from microRNA assessment","volume":"51","author":"Spinka","year":"2021","journal-title":"Eur J Clin Invest"},{"key":"2026012114121113300_ehf214160-bib-0018","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1093\/eurheartj\/ehw106","article-title":"2016 European Guidelines on cardiovascular disease prevention in clinical practice: the Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)","volume":"37","author":"Piepoli","year":"2016","journal-title":"Eur Heart J"},{"key":"2026012114121113300_ehf214160-bib-0019","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"key":"2026012114121113300_ehf214160-bib-0020","article-title":"Neutrophil extracellular trap formation correlates with favorable overall survival in high grade ovarian cancer","volume":"21","author":"Muqaku","year":"2020","journal-title":"Cancer"},{"key":"2026012114121113300_ehf214160-bib-0021","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"2026012114121113300_ehf214160-bib-0022","doi-asserted-by":"crossref","first-page":"I288","DOI":"10.1161\/CIRCULATIONAHA.106.681114","article-title":"Early repair of moderate ischemic mitral regurgitation reverses left ventricular remodeling: a functional and molecular study","volume":"116","author":"Beeri","year":"2007","journal-title":"Circulation"},{"key":"2026012114121113300_ehf214160-bib-0023","doi-asserted-by":"crossref","first-page":"S248","DOI":"10.1161\/CIRCULATIONAHA.112.000124","article-title":"Late repair of ischemic mitral regurgitation does not prevent left ventricular remodeling: importance of timing for beneficial repair","volume":"128","author":"Beaudoin","year":"2013","journal-title":"Circulation"},{"key":"2026012114121113300_ehf214160-bib-0024","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nrm3838","article-title":"Regulation of microRNA biogenesis","volume":"15","author":"Ha","year":"2014","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2026012114121113300_ehf214160-bib-0025","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20051051","article-title":"Lipidomics of bioactive lipids in acute coronary syndromes","volume":"20","author":"Solati","year":"2019","journal-title":"Int J Mol Sci"},{"key":"2026012114121113300_ehf214160-bib-0026","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/nri3859","article-title":"Eicosanoid storm in infection and inflammation","volume":"15","author":"Dennis","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"2026012114121113300_ehf214160-bib-0027","doi-asserted-by":"crossref","first-page":"36059","DOI":"10.1074\/jbc.R100030200","article-title":"Epoxygenase pathways of arachidonic acid metabolism","volume":"276","author":"Zeldin","year":"2001","journal-title":"J Biol Chem"},{"key":"2026012114121113300_ehf214160-bib-0028","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nri915","article-title":"Anti-inflammatory lipid mediators and insights into the resolution of inflammation","volume":"2","author":"Lawrence","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"2026012114121113300_ehf214160-bib-0029","first-page":"135","article-title":"Eicosanoid profiling in effluent of isolated perfused heart of Tg\u03b1q*44 mice with advanced heart failure","volume":"70","author":"Berkowicz","year":"2019","journal-title":"J Physiol Pharmacol: Off J Polish Physiol Soc"},{"key":"2026012114121113300_ehf214160-bib-0030","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1074\/jbc.RA117.000405","article-title":"Heart failure-induced activation of phospholipase iPLA2\u03b3 generates hydroxyeicosatetraenoic acids opening the mitochondrial permeability transition pore","volume":"293","author":"Moon","year":"2018","journal-title":"J Biol Chem"},{"key":"2026012114121113300_ehf214160-bib-0031","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.bbapap.2010.09.009","article-title":"Role of cytochrome P450 enzymes in the bioactivation of polyunsaturated fatty acids","volume":"1814","author":"Konkel","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"2026012114121113300_ehf214160-bib-0032","doi-asserted-by":"crossref","first-page":"R1281","DOI":"10.1152\/ajpregu.00128.2013","article-title":"Human inflammatory and resolving lipid mediator responses to resistance exercise and ibuprofen treatment","volume":"305","author":"Markworth","year":"2013","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"2026012114121113300_ehf214160-bib-0033","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1007\/s00216-012-6226-x","article-title":"Quantitative profiling of oxylipins through comprehensive LC-MS\/MS analysis: application in cardiac surgery","volume":"404","author":"Strassburg","year":"2012","journal-title":"Anal Bioanal Chem"},{"key":"2026012114121113300_ehf214160-bib-0034","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1139\/cjpp-2016-0615","article-title":"Specific plasma oxylipins increase the odds of cardiovascular and cerebrovascular events in patients with peripheral artery disease","volume":"95","author":"Caligiuri","year":"2017","journal-title":"Can J Physiol Pharmacol"},{"key":"2026012114121113300_ehf214160-bib-0035","article-title":"Serum-based oxylipins are associated with outcomes in primary prevention implantable cardioverter defibrillator patients","volume":"11","author":"Zhang","year":"2016","journal-title":"PLoS ONE"},{"key":"2026012114121113300_ehf214160-bib-0036","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1161\/ATVBAHA.108.171298","article-title":"Interaction between P450 eicosanoids and nitric oxide in the control of arterial tone in mice","volume":"29","author":"Hercule","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2026012114121113300_ehf214160-bib-0037","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1056\/NEJMoa1915928","article-title":"Vericiguat in patients with heart failure and reduced ejection fraction","volume":"382","author":"Armstrong","year":"2020","journal-title":"N Engl J Med"},{"key":"2026012114121113300_ehf214160-bib-0038","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N Engl J Med"},{"key":"2026012114121113300_ehf214160-bib-0039","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N Engl J Med"}],"container-title":["ESC Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ehf2.14160","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ehf2.14160","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/10\/1\/311\/65108024\/eschf_10_1_311.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/10\/1\/311\/65108024\/eschf_10_1_311.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T19:13:33Z","timestamp":1769022813000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eschf\/article\/10\/1\/311\/8304953"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,10]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,10,10]]},"published-print":{"date-parts":[[2023,2,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ehf2.14160","relation":{},"ISSN":["2055-5822"],"issn-type":[{"value":"2055-5822","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,2]]},"published":{"date-parts":[[2022,10,10]]},"assertion":[{"value":"2022-08-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-09-08","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-10-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}